Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121682) titled 'A single-arm clinical trial of chidamide combined with reduced-dose R-CHOP in the treatment of newly diagnosed MYC/BCL2 double-expression diffuse large B-cell lymphoma' on April 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chongqing University Cancer Hospital
Condition:
Newly diagnosed diffuse large B-cell lymphoma with MYC/BCL2 double expression
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Experimental group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj...